about
Interferon alpha versus any other drug for chronic hepatitis DManagement of HBV and HBV/HDV-Associated Liver CirrhosisHepatitis delta virus: A fascinating and neglected pathogenTherapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus InfectionHepatitis delta: epidemiology, diagnosis and management 36 years after discoveryInhibitor-Based Therapeutics for Treatment of Viral HepatitisAnti-HDV IgM as a marker of disease activity in hepatitis deltaAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in UgandaBoth interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Increasing incidence of recent hepatitis D virus infection in HIV-infected patients in an area hyperendemic for hepatitis B virus infection.Delta hepatitis-related thyroid disease: a unique phenomenon.Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).Correlation between TH1 response standard cytokines as biomarkers in patients with the delta virus in the western Brazilian AmazonHepatitis D Virus: A Call to Screening.Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Delta virus infection: epidemiology and initiatives to intercept it.Prenylation of viral proteins by enzymes of the host: Virus-driven rationale for therapy with statins and FT/GGT1 inhibitors.Hepatitis delta: virological and clinical aspects.Antiviral treatment and liver-related complications in hepatitis delta.Non-invasive fibrosis score for hepatitis delta.Liver transplantation in a patient with hepatitis B, C and D coinfection associated with hepatocellular carcinoma: a management strategy for a rare condition. Case report.Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.[Which treatment options are validated for chronic viral hepatitis?].Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge
P2860
Q24187640-734919BD-9619-4EEF-8156-A4BD268DC8EFQ26740323-0880CD6F-73BF-410C-83D7-A8AB0CAA7061Q26777052-9F1FAF90-AAB8-4509-B09D-9CAE2C569621Q26795919-6544EE6F-8486-4AF5-9B7A-2C2314DDB49EQ26849602-15140A30-0CC2-47BC-B26A-370C91A513F0Q28073697-ACEA5C86-0D2B-4B02-87DC-05C60B5E4EC9Q28541284-D4EEA7FF-9151-4188-9CA3-4DCBBFB4BF98Q30391932-73B2CB82-CBE9-4AB9-A504-8FB570F550EFQ33584371-D4E3F7CF-E5E6-4702-8060-CD92E65CC08AQ33807794-3A849F5B-0C44-4F65-B4CD-CA832AF54A04Q33813200-1E4955A8-98D3-473A-96B9-6CD29AF7B957Q34045260-C95B0CF2-6F0E-4D5F-9797-BDD04BFD6816Q35043978-E3F2986C-DBDA-4072-8125-17B01F159A09Q36793890-18B6CAFA-A2E1-4D58-82FF-1C10A9CBEE8FQ37182821-64EC997F-989E-49DB-8109-715E5399F939Q37454038-2843040D-92E4-49C3-B2AE-380F549EC3C3Q37540212-75F9EDDE-BCD0-4AB1-B452-6FE1369CAC96Q37698484-2F7CCF90-7073-490E-AF9A-FAAF340F28BBQ40039988-A4B6676F-6180-449F-9317-DAB0C45D4D38Q40042818-08257FAE-C2DC-4B3F-AED6-777117ECA720Q40492331-3A4C839C-675D-4166-9D77-CB4AD0950031Q40610178-CE47F809-D709-4144-A183-3B02ADAB8F6DQ41107378-E2762E57-7A62-484D-85B2-3709049DFF7AQ42223767-1BED9E06-BF2B-4143-BB5E-AD9838397D46Q42234354-E4B0FE33-963B-41FE-BD26-B7973D694CB9Q43759916-16447AB5-C127-4DF1-8B77-8BDC4D08EF81Q55236948-87884D17-F119-4AFD-832B-F39BD9BCE0CEQ56947386-9A27D637-E832-41CF-B120-A7BD6DC72392
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Treatment options for hepatitis delta virus infection.
@en
Treatment options for hepatitis delta virus infection.
@nl
type
label
Treatment options for hepatitis delta virus infection.
@en
Treatment options for hepatitis delta virus infection.
@nl
prefLabel
Treatment options for hepatitis delta virus infection.
@en
Treatment options for hepatitis delta virus infection.
@nl
P2093
P2860
P1476
Treatment options for hepatitis delta virus infection.
@en
P2093
Benjamin Heidrich
Heiner Wedemeyer
Michael P Manns
P2860
P356
10.1007/S11908-012-0307-Z
P577
2013-02-01T00:00:00Z